Search

everythinglearnresearchcommunity

for

Search:↓

Products should be called 'sperm-safe' only after thorough, well-designed tests.

Topical treatments like minoxidil and corticosteroids are effective for hair loss, with JAK inhibitors promising for alopecia areata.

New signs like changes in blood markers, physical symptoms, and behavioral shifts may help detect hidden steroid use in athletes.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

PRP might help with hair growth and skin rejuvenation, but more research is needed to prove its effectiveness.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Differences in gene expression and methylation patterns found in AGA patients suggest potential targets for future treatments.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Hair growth serums A and C can affect hair growth genes and pathways, suggesting potential for personalized hair loss treatments.

Oxidative stress damages hair and contributes to aging, and managing it can help maintain hair health.

Hair ages due to genetics and environmental factors, leading to graying and thinning, with treatments available for some conditions.

The most effective treatments for hair loss are minoxidil, finasteride, PRP, and hair transplants, with steroids and immunosuppressants for autoimmune types.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Hair loss from alopecia areata and androgenetic alopecia can be treated, but more effective and safer treatments are needed.

TRPV3 could be a target for treating pain, skin disorders, and hair problems, but more research is needed to create effective drugs.

Minoxidil can reduce functions related to androgen receptors.

The conclusion suggests a new treatment for infantile hemangiomas and a potential target for hair loss treatment.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

The Ar/miR-221/IGF-1 pathway is involved in male pattern baldness, with miR-221 potentially being a new target for treatment.

The meeting covered advances in understanding hair growth, causes of hair loss, and potential treatments.

Increased PPARGC1α relates to hair thinning in common baldness.

Androgens block hair growth by disrupting cell signals; targeting GSK-3 may help treat hair loss.

A new treatment for hair loss shows promise with fewer side effects.

Melanoma risk tools need improvement, certain gene mutations cause skin diseases and could be treated by targeting those mutations, skin wrinkling may relate to lung aging due to genetic factors, and oxidative stress affects hair loss but can be reduced in low oxygen.

Different substances affect hair and skin cell growth in various ways.

A substance called Cell-free fat extract can effectively treat common hair loss by increasing hair growth and density.

Dihydrotestosterone (DHT) doesn't affect rat skin cell growth, but it does change cell cycle, protein levels, and other cell functions, potentially shortening hair growth cycle.

Different substances affect hair and skin cell growth in various ways, with some promoting and others inhibiting cell proliferation.

DHT reduces a cell's ability to promote hair growth, while 3D culture without DHT improves it.

RE-ORGA, a Korean herb extract, may help prevent hair loss.